论文部分内容阅读
目的探讨治疗多囊卵巢综合征不孕症的药物选择和临床效果。方法选取2015年2月至2016年2月深圳市龙岗区中医院收治的120例多囊卵巢综合征不孕症患者作为研究对象,随机分为观察组与对照组,每组60例。进行基础治疗后,观察组患者采用来曲唑进行治疗,对照组患者给予克罗米芬,比较两组患者的排卵率、妊娠率以及病情好转率。结果观察组患者排卵率为88.3%高于对照组的56.7%,妊娠率为81.7%高于对照组的43.3%,治疗的总有效率为96.7%显著高于对照组的75.0%,组间比较差异均有统计学意义(均P<0.05)。结论来曲唑在治疗多囊卵巢综合征不孕症方面疗效显著,能够有效提高患者的排卵率和妊娠率。
Objective To explore the drug selection and clinical effect of treating infertility with polycystic ovary syndrome. Methods From January 2015 to February 2016, 120 cases of polycystic ovary syndrome infertility patients admitted to Longgang District Chinese Medicine Hospital of Shenzhen were randomly divided into observation group and control group, with 60 cases in each group. After basic treatment, patients in the observation group were treated with letrozole, and patients in the control group were given clomiphene. The ovulation rate, pregnancy rate and improvement rate of the two groups were compared. Results The ovulation rate in observation group was 88.3% higher than 56.7% in control group, the pregnancy rate was 81.7% higher than 43.3% in control group, the total effective rate was 96.7%, significantly higher than 75.0% in control group The differences were statistically significant (all P <0.05). Conclusion Letrozole is effective in treating infertility with polycystic ovary syndrome and can effectively improve the ovulation rate and pregnancy rate of the patients.